Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sahm

Showing results (51-60 of 449) with videos related to

Pageof 45
Sort By:
Journal of Biophotonics|June 14, 2019
Identification of distinctive features in human intracranial tumors by label-free nonlinear multimodal microscopyRoberta Galli, Ortrud Uckermann, Tina Sehm, et al.
Pathology Oncology Research : POR|June 16, 2022
Progression Patterns in Non-Contrast-Enhancing Gliomas Support Brain Tumor Responsiveness to Surgical LesionsSteffen Brenner, Sebastian Hartzendorf, Philip Vogt, et al.
Acta Neuropathologica|November 12, 2010
Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphologyDavid Capper, David Reuss, Jens Schittenhelm, et al.
Nature Communications|February 20, 2025
Explainable artificial intelligence of DNA methylation-based brain tumor diagnosticsSalvatore Benfatto, Martin Sill, David T W Jones, et al.
Neuro-Oncology|September 4, 2020
TERT and DNMT1 expression predict sensitivity to decitabine in gliomasJong-Whi Park, Felix Sahm, Bianca Steffl, et al.
World Neurosurgery|March 5, 2023
Cerebellar Mutism Syndrome After Posterior Fossa Tumor Surgery in Children-A Retrospective Single-Center StudyStephanie Schmidt, Edina Kovacs, Diren Usta, et al.
Journal of Neuro-Oncology|March 11, 2026
Prognostic relevance of resection at first recurrence in isocitrate dehydrogenase mutant lower-grade glioma: results from a retrospective, single-center, volumetric analysisChristine Jungk, Karla Goepfert, Mara Gluszak, et al.
Neuro-Oncology Advances|October 9, 2024
Aggressive high-grade NF2 mutant meningiomas downregulate oncogenic YAP signaling via the upregulation of VGLL4 and FAT3/4Abigail G Parrish, Sonali Arora, H Nayanga Thirimanne, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2024
Aggressive high-grade NF2 mutant meningiomas downregulate oncogenic YAP signaling via the upregulation of VGLL4 and FAT3/4Abigail G Parrish, Sonali Arora, H Nayanga Thirimanne, et al.
Acta Neuropathologica|June 4, 2011
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibodyDavid Capper, Matthias Preusser, Antje Habel, et al.
Pageof 45

Showing results (51-60 of 449) with videos related to

Sort By:
Pageof 45
Journal of Biophotonics|June 14, 2019
Identification of distinctive features in human intracranial tumors by label-free nonlinear multimodal microscopyRoberta Galli, Ortrud Uckermann, Tina Sehm, et al.
Pathology Oncology Research : POR|June 16, 2022
Progression Patterns in Non-Contrast-Enhancing Gliomas Support Brain Tumor Responsiveness to Surgical LesionsSteffen Brenner, Sebastian Hartzendorf, Philip Vogt, et al.
Acta Neuropathologica|November 12, 2010
Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphologyDavid Capper, David Reuss, Jens Schittenhelm, et al.
Nature Communications|February 20, 2025
Explainable artificial intelligence of DNA methylation-based brain tumor diagnosticsSalvatore Benfatto, Martin Sill, David T W Jones, et al.
Neuro-Oncology|September 4, 2020
TERT and DNMT1 expression predict sensitivity to decitabine in gliomasJong-Whi Park, Felix Sahm, Bianca Steffl, et al.
World Neurosurgery|March 5, 2023
Cerebellar Mutism Syndrome After Posterior Fossa Tumor Surgery in Children-A Retrospective Single-Center StudyStephanie Schmidt, Edina Kovacs, Diren Usta, et al.
Journal of Neuro-Oncology|March 11, 2026
Prognostic relevance of resection at first recurrence in isocitrate dehydrogenase mutant lower-grade glioma: results from a retrospective, single-center, volumetric analysisChristine Jungk, Karla Goepfert, Mara Gluszak, et al.
Neuro-Oncology Advances|October 9, 2024
Aggressive high-grade NF2 mutant meningiomas downregulate oncogenic YAP signaling via the upregulation of VGLL4 and FAT3/4Abigail G Parrish, Sonali Arora, H Nayanga Thirimanne, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2024
Aggressive high-grade NF2 mutant meningiomas downregulate oncogenic YAP signaling via the upregulation of VGLL4 and FAT3/4Abigail G Parrish, Sonali Arora, H Nayanga Thirimanne, et al.
Acta Neuropathologica|June 4, 2011
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibodyDavid Capper, Matthias Preusser, Antje Habel, et al.
Pageof 45